Subscribe To
Morphosys' licensing partner roche received breakthrough therapy designation for gantenerumab in alzheimer's disease
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 11, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that its licensing partner ...
October 11, 2021, 3:10 am
Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the roche Group (SIX: RO, ROG; OTC...
October 8, 2021, 4:48 pm
Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the roche Group (SIX: RO, ROG; OTC...
October 8, 2021, 4:48 pm
Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the roche Group (SIX: RO, ROG; OTC...
October 8, 2021, 4:48 pm
Roche's alzheimer's candidate secures fda breakthrough designation
roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Roche's alzheimer's candidate secures fda breakthrough designation
roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Roche's alzheimer's candidate secures fda breakthrough designation
roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the roche Group (SIX: RO, ROG; OTC...
October 8, 2021, 11:40 am
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the roche Group (SIX: RO, ROG; OTC...
October 8, 2021, 11:40 am
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the roche Group (SIX: RO, ROG; OTC...
October 8, 2021, 11:40 am
Littlejohn & co. completes sale of hydrochempsc to clean harbors
GREENWICH, Conn.--(BUSINESS WIRE)--Littlejohn & Co. LLC, a private investment firm based in Greenwich, CT, today announced the successful completion o...
October 8, 2021, 11:26 am
Littlejohn & co. completes sale of hydrochempsc to clean harbors
GREENWICH, Conn.--(BUSINESS WIRE)--Littlejohn & Co. LLC, a private investment firm based in Greenwich, CT, today announced the successful completion o...
October 8, 2021, 11:26 am
Littlejohn & co. completes sale of hydrochempsc to clean harbors
GREENWICH, Conn.--(BUSINESS WIRE)--Littlejohn & Co. LLC, a private investment firm based in Greenwich, CT, today announced the successful completion o...
October 8, 2021, 11:26 am
Clean harbors completes acquisition of hydrochempsc
NORWELL, Mass.--(BUSINESS WIRE)--Clean Harbors, Inc. (“Clean Harbors”) (NYSE: CLH) today announced the completion of its acquisition of HydroChemP...
October 8, 2021, 11:23 am
Clean harbors completes acquisition of hydrochempsc
NORWELL, Mass.--(BUSINESS WIRE)--Clean Harbors, Inc. (“Clean Harbors”) (NYSE: CLH) today announced the completion of its acquisition of HydroChemP...
October 8, 2021, 11:23 am
Clean harbors completes acquisition of hydrochempsc
NORWELL, Mass.--(BUSINESS WIRE)--Clean Harbors, Inc. (“Clean Harbors”) (NYSE: CLH) today announced the completion of its acquisition of HydroChemP...
October 8, 2021, 11:23 am
Vuzix and ambifi join forces to provide ambient technology solutions for healthcare practitioners
Vuzix Corporation, a leading supplier of Smart Glasses and augmented reality (AR) technology and products, said it has partnered with AmbiFi, an advan...
October 7, 2021, 1:57 pm
Vuzix and ambifi join forces to provide ambient technology solutions for healthcare practitioners
Vuzix Corporation, a leading supplier of Smart Glasses and augmented reality (AR) technology and products, said it has partnered with AmbiFi, an advan...
October 7, 2021, 1:57 pm
Vuzix and ambifi join forces to provide ambient technology solutions for healthcare practitioners
Vuzix Corporation, a leading supplier of Smart Glasses and augmented reality (AR) technology and products, said it has partnered with AmbiFi, an advan...
October 7, 2021, 1:57 pm
Vuzix and ambifi join forces to provide ambient technology solutions for healthcare practitioners
ROCHESTER, N.Y., Oct. 7, 2021 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses a...
October 7, 2021, 1:10 pm